MEETS

Clinically meaningful achievement of primary and secondary endpoints is first major advance in treatment of low-grade glioma in more than 20 yearsEndpoints met in a prespecified interim analysisvorasidenib granted fast track designation by…

NEW DELHI, March 9, 2023 /PRNewswire/ -- The amalgamation of modern and traditional fashion has a new name; Divya Aggarwal, a vision of redefining the Indian couture world. Designer, founder, and a woman of substance, Divya Aggarwal…

Originating in the timeless city of Banaras (Benaras), the clothing brand Chinaya has gained quite the repute for its focus on the fusion of India’s rich culture and heritage with authentic apparel designs. The online retailer offers…

KUNSHAN, China, March 2, 2023 /PRNewswire/ -- Arctech, the world's leading solar tracking, racking, and BIPV provider welcomed the senior management from ACWA Power and China Energy Engineering Group Co., Ltd. (hereafter "CEEC") at a…

LOS ANGELES--(BUSINESS WIRE)--#charity--Project Venkman, in partnership with Gold Meets Golden, is excited to announce a celebrity VIP experience auction, benefitting Angel City Sports. The auction, which will end on February 28, will…

WASHINGTON, DC, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Community Activist and Leader Zahid F. Sarder Saddi recently met with Congressman Darren Soto shortly after he was sworn in for a subsequent term, taking his oath of office in the House…

PRESS RELEASE:  REGULATED INFORMATION17 January 2023, 17:40 CET BIOCARTIS MEETS 2022 KEY OBJECTIVES Mechelen, Belgium, 17 January 2023 - Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company…

Distressed by the issue of the successive construction bans, the real estate sector today met Hon'ble Union Minister, Shri. Bhupendra Yadav, Minister Environment, Forest and Climate Change. During this meeting, many distinguished…

BBS-Bioactive Bone Substitutes Plc, Investor News, 22 December 2022 at 3.45 p.m. The management team of BBS-Bioactive Bone Substitutes Plc (BBS), including CEO Ilkka Kangasniemi, Chairman of the Board Jarmo Halonen, and Board…

Statistically significant improvements in lung function, symptoms and quality of life 36% reduction in rate of exacerbations over 24 weeks Well tolerated safety profile over 48 weeks NDA submission planned for 1H 2023 Conference…